BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7611244)

  • 1. Macrophages and progressive renal disease in experimental hydronephrosis.
    Diamond JR
    Am J Kidney Dis; 1995 Jul; 26(1):133-40. PubMed ID: 7611244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myofibroblasts in experimental hydronephrosis.
    Diamond JR; van Goor H; Ding G; Engelmyer E
    Am J Pathol; 1995 Jan; 146(1):121-9. PubMed ID: 7856721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of macrophages and reactive oxygen species in experimental hydronephrosis.
    Ricardo SD; Diamond JR
    Semin Nephrol; 1998 Nov; 18(6):612-21. PubMed ID: 9819152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis.
    Engelmyer E; van Goor H; Edwards DR; Diamond JR
    J Am Soc Nephrol; 1995 Mar; 5(9):1675-83. PubMed ID: 7780056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstructive uropathy.
    Truong LD; Gaber L; Eknoyan G
    Contrib Nephrol; 2011; 169():311-326. PubMed ID: 21252529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of macrophages, myofibroblasts, and transforming growth factor-beta localization during rat renal interstitial fibrosis following long-term unilateral ureteral obstruction.
    Yamate J; Okado A; Kuwamura M; Tsukamoto Y; Ohashi F; Kiso Y; Nakatsuji S; Kotani T; Sakuma S; Lamarre J
    Toxicol Pathol; 1998; 26(6):793-801. PubMed ID: 9864097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased transforming growth factor-beta1 and tubulointerstitial fibrosis in rats with congenital hydronephrosis.
    Zhou Y; Takahashi G; Shinagawa T; Okuhara T; Yonamine K; Aida Y; Tadokoro M
    Int J Urol; 2002 Sep; 9(9):491-500. PubMed ID: 12410929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat.
    Duymelinck C; Dauwe SE; De Greef KE; Ysebaert DK; Verpooten GA; De Broe ME
    Kidney Int; 2000 Sep; 58(3):1186-201. PubMed ID: 10972681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights into renal interstitial fibrosis.
    Eddy AA
    J Am Soc Nephrol; 1996 Dec; 7(12):2495-508. PubMed ID: 8989727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of interstitial fibrosis in obstructive nephropathy.
    Diamond JR; Ricardo SD; Klahr S
    Semin Nephrol; 1998 Nov; 18(6):594-602. PubMed ID: 9819150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial macrophages as mediators of renal fibrosis.
    Eddy AA
    Exp Nephrol; 1995; 3(2):76-9. PubMed ID: 7773640
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis.
    Diamond JR; Kees-Folts D; Ding G; Frye JE; Restrepo NC
    Am J Physiol; 1994 Jun; 266(6 Pt 2):F926-33. PubMed ID: 7517644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myofibroblast phenotypes expression in experimental renal scarring.
    Muchaneta-Kubara EC; el Nahas AM
    Nephrol Dial Transplant; 1997 May; 12(5):904-15. PubMed ID: 9175042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of decorin in experimental hydronephrosis.
    Diamond JR; Levinson M; Kreisberg R; Ricardo SD
    Kidney Int; 1997 Apr; 51(4):1133-9. PubMed ID: 9083279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.
    Neelisetty S; Alford C; Reynolds K; Woodbury L; Nlandu-Khodo S; Yang H; Fogo AB; Hao CM; Harris RC; Zent R; Gewin L
    Kidney Int; 2015 Sep; 88(3):503-14. PubMed ID: 25760325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: lymphocyte infiltration is not required for progressive tubulointerstitial injury.
    Shappell SB; Gurpinar T; Lechago J; Suki WN; Truong LD
    J Am Soc Nephrol; 1998 Jun; 9(6):1008-17. PubMed ID: 9621283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
    Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
    Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphometry of interstitial fibrosis.
    De Heer E; Sijpkens YW; Verkade M; den Dulk M; Langers A; Schutrups J; Bruijn JA; van Es LA
    Nephrol Dial Transplant; 2000; 15 Suppl 6():72-3. PubMed ID: 11143998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy.
    Ishidoya S; Morrissey J; McCracken R; Klahr S
    Kidney Int; 1996 Apr; 49(4):1110-9. PubMed ID: 8691732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction.
    Summers SA; Gan PY; Dewage L; Ma FT; Ooi JD; O'Sullivan KM; Nikolic-Paterson DJ; Kitching AR; Holdsworth SR
    Kidney Int; 2012 Sep; 82(6):676-85. PubMed ID: 22673890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.